ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France.
Abivax Sa stock last closed at $102.47, down 6.4% from the previous day, and has increased 1,402.49% in one year. It has overperformed other stocks in the Biotechnology industry by 14.42 percentage points. Abivax Sa stock is currently +2,048.22% from its 52-week low of $4.77, and -31.15% from its 52-week high of $148.83.
At the moment, there are 78.54M ABVX shares outstanding. The market capitalization of ABVX is $8.05B. In the past 24 hours, 1.75M ABVX shares were traded.
How to Buy Abivax Sa Stock
Not sure how to invest in Abivax Sa stock? Here's how.
Decide where to buy Abivax Sa stock: You need to choose a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you figure out where to buy Abivax Sa stock.
Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit money your investment account: Choose your payment method and add your details.
Analyze Abivax Sa stock: The Abivax Sa ticker symbol is ABVX. Is Abivax Sa stock a good investment? Should you buy shares of ABVX? How do ABVX's underlying business fundamentals look? Do top analysts think Abivax Sa is a good buy? Why has ABVX's stock price moved recently? (Hint: Our stock market research website can help you evaluate if ABVX is a good stock to buy).
Place your ABVX purchase: Decide if you will purchase ABVX shares at the current market price or use a limit order to buy ABVX stock at a given price.
Keep an eye on your investment in ABVX: Create a watchlist to track your position in Abivax Sa shares.
Step 1: Decide where to buy Abivax Sa stock
You will need a brokerage account to access the NASDAQ market and buy ABVX stock.
A brokerage account is an investment account that allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
In our opinion, eToro is the best place to buy stocks. eToro gives you:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to world financial markets: From Technology to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal information so you can buy ABVX today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Abivax Sa stock
Once you have figured out the best place to buy Abivax Sa stock, it's critical to research their stock before you buy, so you truly comprehend the risk as well as the upside.
Overview of key ABVX info
ABVX Price
$102.47
1w %
-14.85%
1y %
1,402.49%
5y %
N/A
P/E
-18.46x
P/B
15.38x
P/S
1,348.29x
PEG
N/A
Revenue
$5.25M
Earnings
-$386.32M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$8.05B
Next Earnings
N/A
Next Dividend
N/A
Abivax Sa Due Diligence Checks
WallStreetZen was created to help everyday investors do more in-depth fundamental analysis in less time.
ABVX has cash burn of 185368965. It has sufficient cash and short-term investments to cover this for at least one year.
There are more short-term assets than long-term liabilities on the ABVX balance sheet.
ABVX has $618.51M in cash and short term investments. This is sufficient to cover its annual cash burn of $185.37M.
There are more short-term assets than short-term liabilities on the ABVX balance sheet.
ABVX has a low debt to equity ratio of 0.28.
Signs that ABVX is not financially healthy:
ABVX profit margin has gone down from -1,415.7% to -7,354.5% in the past year.
Is ABVX stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 9 Wall Street analysts who give ratings on ABVX, the consensus analyst rating on ABVX is a Strong Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
Latest ABVX Analyst Forecasts
Jason Butler, a top 2% analyst from Citizens maintains ABVX with a buy rating and raises their ABVX price target from $114.00 to $131.00, on Dec 16, 2025.
Gregory Renza, a top 3% analyst from Truist Securities initiates coverage on ABVX with a strong buy rating and announces their ABVX price target of $140.00, on Nov 24, 2025.
Steve Fleishman, a top 21% analyst from Wolfe Research initiates coverage on ABVX with a buy rating and announces their ABVX price target of $176.00, on Nov 6, 2025.
Yatin Suneja, a top 3% analyst from Guggenheim maintains ABVX with a strong buy rating and raises their ABVX price target from $101.00 to $150.00, on Oct 10, 2025.
Guggenheim's Yatin Suneja raised their price target on Abivax SA (NASDAQ: ABVX) by 48.5% from $101 to $150 on 2025/10/10. The analyst maintained their Strong Buy rating on the stock.
Naming the stock their Best Idea, Suneja attributed the move and their price target hike to takeaways from the UEGW conference in Berlin and an investor dinner with Abivax SA's management team.
The analyst told readers that there was "unanimous agreement" among key opinion leaders at the conference that the use and adoption of obefazimod is likely to be broad from front-line to later-line usage, positioning the drug to become "the cornerstone oral treatment" for ulcerative colitis.
Last year, ABVX revenue was $5.25M. In the last 4 year, ABVX's revenue has grown by -20.69% per year. This was slower than the Biotechnology industry average of 29.01%.
No, Abivax Sa doesn't provide an income stream by paying out dividends.
ABVX Social Trading Data
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Place your ABVX purchase
You have two primary options:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are mostly fine.
Limit order: A limit order allows you to buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at an exact dollar amount limit, use a limit order.
Hit the Open button and eToro will place the order.
If you want additional help investing in stocks on eToro, watch the how to video below:
As of Mar 27, 2026, it costs $102.47 to buy one share of Abivax Sa stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.098 shares of ABVX.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.